Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk.

Andrew AS, Chen CY, Caller TA, Tandan R, Henegan PL, Jackson BP, Hall BP, Bradley WG, Stommel EW.

Muscle Nerve. 2018 Jan 4. doi: 10.1002/mus.26055. [Epub ahead of print]

2.

Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS).

Kuczmarski T, Stommel EW, Riley K, Tandan R, Chaudhry V, Clawson L, Caller TA, Henegan PL, Facciponte DN, Bradley WG, Andrew AS.

J Neurol. 2017 Aug;264(8):1763-1767. doi: 10.1007/s00415-017-8564-2. Epub 2017 Jul 15.

PMID:
28711998
3.

Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New England.

Andrew AS, Caller TA, Tandan R, Duell EJ, Henegan PL, Field NC, Bradley WG, Stommel EW.

Neurodegener Dis. 2017;17(2-3):110-116. doi: 10.1159/000453359. Epub 2017 Jan 26.

4.

A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy.

Caller TA, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson TD, Henegan PL, Birney K, Jobst BC.

Epilepsy Behav. 2016 Apr;57(Pt A):111-117. doi: 10.1016/j.yebeh.2016.01.024. Epub 2016 Mar 2.

PMID:
26943948
5.

Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland.

Bradley WG, Stommel EW, Shi X, Torbick NM, Caller TA, Sabel CE, Rooney JP, Staines A, Hardiman O.

Neurology. 2015 Nov 17;85(20):1822-3. doi: 10.1212/01.wnl.0000473800.89178.a9. No abstract available.

PMID:
26574539
6.

Discharge Delays for Patients Requiring In-Hospital Guardianship: A Cohort Analysis.

Chen JJ, Finn CT, Homa K, St Onge KP, Caller TA.

J Healthc Qual. 2016 Jul-Aug;38(4):235-42. doi: 10.1097/01.JHQ.0000462680.47759.53.

PMID:
26042759
7.

The Epidemiology of Amyotrophic Lateral Sclerosis in New Hampshire, USA, 2004-2007.

Caller TA, Andrews A, Field NC, Henegan PL, Stommel EW.

Neurodegener Dis. 2015;15(4):202-6. doi: 10.1159/000374117. Epub 2015 Apr 16.

PMID:
25896575
8.

Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy.

Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC.

Epilepsy Behav. 2015 Mar;44:192-4. doi: 10.1016/j.yebeh.2014.12.036. Epub 2015 Feb 27.

PMID:
25731132
9.

Reducing severity of comorbid psychiatric symptoms in an epilepsy clinic using a colocation model: results of a pilot intervention.

Chen JJ, Caller TA, Mecchella JN, Thakur DS, Homa K, Finn CT, Kobylarz EJ, Bujarski KA, Thadani VM, Jobst BC.

Epilepsy Behav. 2014 Oct;39:92-6. doi: 10.1016/j.yebeh.2014.07.015. Epub 2014 Sep 18.

PMID:
25238553
10.

Predictors for readmissions after video-EEG monitoring.

Caller TA, Chen JJ, Harrington JJ, Bujarski KA, Jobst BC.

Neurology. 2014 Jul 29;83(5):450-5. doi: 10.1212/WNL.0000000000000647. Epub 2014 Jun 20.

11.

Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009.

Caller TA, Chipman JW, Field NC, Stommel EW.

Muscle Nerve. 2013 Aug;48(2):235-41. doi: 10.1002/mus.23761.

PMID:
23881670
12.

Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.

Field NC, Metcalf JS, Caller TA, Banack SA, Cox PA, Stommel EW.

Toxicon. 2013 Aug;70:179-83. doi: 10.1016/j.toxicon.2013.04.010. Epub 2013 May 6.

PMID:
23660330
13.

Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.

Stommel EW, Field NC, Caller TA.

Med Hypotheses. 2013 Feb;80(2):142-5. doi: 10.1016/j.mehy.2012.11.012. Epub 2012 Dec 14.

PMID:
23246360
14.

Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.

Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW.

Amyotroph Lateral Scler. 2012 Jan;13(1):25-32. doi: 10.3109/17482968.2011.621436. Review.

PMID:
22214351
15.

The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.

Banack SA, Caller TA, Stommel EW.

Toxins (Basel). 2010 Dec;2(12):2837-50. doi: 10.3390/toxins2122837. Epub 2010 Dec 20. Review.

16.

An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.

Field NC, Caller TA, Stommel EW.

Med Hypotheses. 2011 Oct;77(4):565-7. doi: 10.1016/j.mehy.2011.06.032. Epub 2011 Jul 13.

PMID:
21745715
17.

A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.

Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, Ball A, Harris BT, Stommel EW.

Amyotroph Lateral Scler. 2009;10 Suppl 2:101-8. doi: 10.3109/17482960903278485.

PMID:
19929741

Supplemental Content

Loading ...
Support Center